178 related articles for article (PubMed ID: 31130145)
1. Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data.
DeVivo R; Zajac L; Mian A; Cervantes-Arslanian A; Steinberg E; Alosco ML; Mez J; Stern R; Killany R;
J Int Neuropsychol Soc; 2019 Sep; 25(8):800-810. PubMed ID: 31130145
[TBL] [Abstract][Full Text] [Related]
2. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
[TBL] [Abstract][Full Text] [Related]
3. Differential medial temporal lobe and default-mode network functional connectivity and morphometric changes in Alzheimer's disease.
Grajski KA; Bressler SL;
Neuroimage Clin; 2019; 23():101860. PubMed ID: 31158694
[TBL] [Abstract][Full Text] [Related]
4. T2 Relaxometry and Diffusion Tensor Indices of the Hippocampus and Entorhinal Cortex Improve Sensitivity and Specificity of MRI to Detect Amnestic Mild Cognitive Impairment and Alzheimer's Disease Dementia.
Knight MJ; Wearn A; Coulthard E; Kauppinen RA
J Magn Reson Imaging; 2019 Feb; 49(2):445-455. PubMed ID: 30209854
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
[TBL] [Abstract][Full Text] [Related]
6. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
8. Structural neuroimaging correlates of cognitive status in older adults: A person-oriented approach.
Malpas CB
J Clin Neurosci; 2016 Aug; 30():77-82. PubMed ID: 27056675
[TBL] [Abstract][Full Text] [Related]
9. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
Teipel S; Grothe MJ;
J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
[TBL] [Abstract][Full Text] [Related]
10. Exploring Structural and Functional Brain Changes in Mild Cognitive Impairment: A Whole Brain ALE Meta-Analysis for Multimodal MRI.
Gu L; Zhang Z
ACS Chem Neurosci; 2019 Jun; 10(6):2823-2829. PubMed ID: 30808171
[TBL] [Abstract][Full Text] [Related]
11. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
12. Regional Cerebral Blood Flow in the Posterior Cingulate and Precuneus and the Entorhinal Cortical Atrophy Score Differentiate Mild Cognitive Impairment and Dementia Due to Alzheimer Disease.
Thomas B; Sheelakumari R; Kannath S; Sarma S; Menon RN
AJNR Am J Neuroradiol; 2019 Oct; 40(10):1658-1664. PubMed ID: 31515217
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
14. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
Chetelat G; Baron JC
Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
[TBL] [Abstract][Full Text] [Related]
16. Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Zhao H; Li X; Wu W; Li Z; Qian L; Li S; Zhang B; Xu Y
PLoS One; 2015; 10(6):e0130017. PubMed ID: 26066658
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
19. Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment.
Kulason S; Tward DJ; Brown T; Sicat CS; Liu CF; Ratnanather JT; Younes L; Bakker A; Gallagher M; Albert M; Miller MI;
Neuroimage Clin; 2019; 21():101617. PubMed ID: 30552075
[TBL] [Abstract][Full Text] [Related]
20. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
